Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis

Background: A recent review by the International Agency for Research on Cancer (IARC) updated the assessments of the > 100 agents classified as Group 1, carcinogenic to humans (IARC Monographs Volume 100, parts A–F). This exercise was complicated by the absence of a broadly accepted, systematic method for evaluating mechanistic data to support conclusions regarding human hazard from exposure to carcinogens. Objectives and Methods: IARC therefore convened two workshops in which an international Working Group of experts identified 10 key characteristics, one or more of which are commonly exhibited by established human carcinogens. Discussion: These characteristics provide the basis for an objective approach to identifying and organizing results from pertinent mechanistic studies. The 10 characteristics are the abilities of an agent to 1) act as an electrophile either directly or after metabolic activation; 2) be genotoxic; 3) alter DNA repair or cause genomic instability; 4) induce epigenetic alterations; 5) induce oxidative stress; 6) induce chronic inflammation; 7) be immunosuppressive; 8) modulate receptor-mediated effects; 9) cause immortalization; and 10) alter cell proliferation, cell death, or nutrient supply. Conclusion: We describe the use of the 10 key characteristics to conduct a systematic literature search focused on relevant end points and construct a graphical representation of the identified mechanistic information. Next, we use benzene and polychlorinated biphenyls as examples to illustrate how this approach may work in practice. The approach described is similar in many respects to those currently being implemented by the U.S. EPA’s Integrated Risk Information System Program and the U.S. National Toxicology Program. Citation: Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I, DeMarini DM, Caldwell JC, Kavlock RJ, Lambert P, Hecht SS, Bucher JR, Stewart BW, Baan R, Cogliano VJ, Straif K. 2016. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect 124:713–721; http://dx.doi.org/10.1289/ehp.1509912

[1]  E. Walshaw,et al.  A systematic approach , 2018, BDJ.

[2]  Y. Shukla,et al.  Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer. , 2016, Biochemical and biophysical research communications.

[3]  Ivan Rusyn,et al.  Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review. , 2016, Mutation research. Reviews in mutation research.

[4]  Shih-Heng Chen,et al.  Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration. , 2016, Current opinion in pharmacology.

[5]  H. Druckrey,et al.  4 The relation of Cancer Induction and Genetic Damage , 2016 .

[6]  Polybrominated Biphenyls Polychlorinated Biphenyls and Polybrominated Biphenyls. , 2016, IARC monographs on the evaluation of carcinogenic risks to humans.

[7]  P. Tsao,et al.  Diabetic Cardiovascular Disease Induced by Oxidative Stress , 2015, International journal of molecular sciences.

[8]  Kurt Straif,et al.  Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid. , 2015, The Lancet. Oncology.

[9]  C. Harris Cause and Prevention of Human Cancer. , 2015, Carcinogenesis.

[10]  W. Rathmell,et al.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. , 2015, Carcinogenesis.

[11]  Anna C. Salzberg,et al.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead , 2015, Carcinogenesis.

[12]  Kurt Straif,et al.  Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate. , 2015, The Lancet. Oncology.

[13]  Thomas M. Keane,et al.  The mutational landscapes of genetic and chemical models of Kras-driven lung cancer , 2014, Nature.

[14]  D Andrews,et al.  Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 , 2014, Cell Death and Differentiation.

[15]  T. Douki,et al.  DNA damage in internal organs after cutaneous exposure to sulphur mustard. , 2014, Toxicology and applied pharmacology.

[16]  Tracey J. Woodruff,et al.  The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Human Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.

[17]  Division on Earth Review of Epa's Integrated Risk Information System (Iris) Process , 2014 .

[18]  Paula I. Johnson,et al.  The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Nonhuman Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.

[19]  John R. Bucher,et al.  Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.

[20]  H. Naegeli,et al.  Low-Dose Formaldehyde Delays DNA Damage Recognition and DNA Excision Repair in Human Cells , 2014, PloS one.

[21]  S. H. Baek,et al.  Emerging roles of orphan nuclear receptors in cancer. , 2014, Annual review of physiology.

[22]  S. Ryter,et al.  The Impact of Autophagy on Cell Death Modalities , 2014, International journal of cell biology.

[23]  Ivan Rusyn,et al.  A systematic approach for identifying and presenting mechanistic evidence in human health assessments. , 2013, Regulatory toxicology and pharmacology : RTP.

[24]  M. Allday EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection , 2013, Front. Genet..

[25]  Paolo Vineis,et al.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. , 2013, Carcinogenesis.

[26]  Melvin E. Andersen,et al.  Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  A. Camargo,et al.  Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. , 2013, Antioxidants & redox signaling.

[28]  M. Little,et al.  Non-targeted effects of ionising radiation--implications for low dose risk. , 2013, Mutation research.

[29]  K. Straif,et al.  Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. , 2013, The Lancet. Oncology.

[30]  M. Banerjee,et al.  Role of genomic instability in arsenic-induced carcinogenicity. A review. , 2013, Environment international.

[31]  M. Redinbo,et al.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective , 2013, Drug metabolism reviews.

[32]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[33]  Robert J Kavlock,et al.  In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  Ivan Rusyn,et al.  Environmental toxicants, epigenetics, and cancer. , 2013, Advances in experimental medicine and biology.

[35]  David M. Wilson,et al.  Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. , 2012, Cancer letters.

[36]  Stephen S Hecht,et al.  Lung carcinogenesis by tobacco smoke , 2012, International journal of cancer.

[37]  M. Filipič Mechanisms of cadmium induced genomic instability. , 2012, Mutation research.

[38]  Gabriele Multhoff,et al.  Radiation, Inflammation, and Immune Responses in Cancer , 2012, Front. Oncol..

[39]  G. Trinchieri Cancer and inflammation: an old intuition with rapidly evolving new concepts. , 2012, Annual review of immunology.

[40]  P. Bugelski,et al.  Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice , 2012, Journal of immunotoxicology.

[41]  Luoping Zhang,et al.  Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. , 2012, Carcinogenesis.

[42]  Kurt Straif,et al.  Preventable exposures associated with human cancers. , 2011, Journal of the National Cancer Institute.

[43]  Q. Ma Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease , 2011, Expert opinion on drug metabolism & toxicology.

[44]  Shaoyu Zhou,et al.  Oxidative stress and oxidative damage in chemical carcinogenesis. , 2011, Toxicology and applied pharmacology.

[45]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[46]  L. Coussens,et al.  Leukocytes in mammary development and cancer. , 2011, Cold Spring Harbor perspectives in biology.

[47]  J. Higgins Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[48]  B. Pons,et al.  Direct inhibition of excision/synthesis DNA repair activities by cadmium: analysis on dedicated biochips. , 2010, Mutation research.

[49]  E. Robertson,et al.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention , 2010, Cancer biology & therapy.

[50]  T. Kunkel,et al.  Mutator phenotypes due to DNA replication infidelity. , 2010, Seminars in cancer biology.

[51]  B. Preston,et al.  DNA replication fidelity and cancer. , 2010, Seminars in cancer biology.

[52]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[53]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[54]  D. DeMarini,et al.  Types and Consequences of DNA Damage , 2009 .

[55]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[56]  D. DeMarini,et al.  Chemoprevention of Cancer and DNA Damage by Dietary Factors , 2009 .

[57]  Jiri Aubrecht,et al.  Community address: www.elsevier.com/locate/mutres Review , 2022 .

[58]  T. Kiyono,et al.  Molecular mechanisms of cervical carcinogenesis by high‐risk human papillomaviruses: novel functions of E6 and E7 oncoproteins , 2009, Reviews in medical virology.

[59]  J. Pollard,et al.  Macrophages define the invasive microenvironment in breast cancer , 2008, Journal of leukocyte biology.

[60]  A. Zhitkovich,et al.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. , 2008, Chemical research in toxicology.

[61]  humAn cArcinogens,et al.  IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). , 2008, IARC monographs on the evaluation of carcinogenic risks to humans.

[62]  K. Straif,et al.  Carcinogenicity of 1,3-butadiene, ethylene oxide, vinyl chloride, vinyl fluoride, and vinyl bromide. , 2007, The Lancet. Oncology.

[63]  M. Kazanietz,et al.  Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.

[64]  P. Hartge,et al.  Environmental and Behavioral Factors and the Risk of Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[65]  Lawrence D True,et al.  Human cancers express a mutator phenotype , 2006, Proceedings of the National Academy of Sciences.

[66]  Ivan Rusyn,et al.  Effects of ethylene oxide and ethylene inhalation on DNA adducts, apurinic/apyrimidinic sites and expression of base excision DNA repair genes in rat brain, spleen, and liver. , 2005, DNA repair.

[67]  F. O’Sullivan,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.

[68]  D. Mankoff,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by ( 18 F)Fluoromisonidazole and ( 18 F)Fluorodeoxyglucose Positron , 2004 .

[69]  G. Morgan,et al.  Causal models of leukaemia and lymphoma. , 2004, IARC scientific publications.

[70]  A. Kong,et al.  Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. , 2002, Current drug metabolism.

[71]  Á. Pascual,et al.  Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.

[72]  C. Walker Polychlorinated biphenyls and polybrominated biphenyls , 2001 .

[73]  A. Klingelhutz The roles of telomeres and telomerase in cellular immortalization and the development of cancer. , 1999, Anticancer research.

[74]  Martyn T. Smith,et al.  The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. , 1996, Environmental health perspectives.

[75]  L. Ehrenberg Covalent binding of genotoxic agents to proteins and nucleic acids. , 1984, IARC scientific publications.

[76]  T. Slaga,et al.  Multistage chemical carcinogenesis in mouse skin. , 1980, Current problems in dermatology.

[77]  J A Miller,et al.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.